Enalapril/hydrochlorothiazide
| Combination of | |
|---|---|
| Enalapril | ACE inhibitor |
| Hydrochlorothiazide | Thiazide diuretic |
| Clinical data | |
| Trade names | Vaseretic, others |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a601047 |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| KEGG | |
Enalapril/hydrochlorothiazide, sold under the brand name Vaseretic among others, is a fixed-dose combination medication used for the treatment of hypertension (high blood pressure).[2] It contains enalapril, an angiotensin converting enzyme inhibitor, and hydrochlorothiazide a diuretic.[2] It is taken by mouth.[2]
The most frequent side effects include dizziness, headache, fatigue, and cough.[2]
History
Enalapril/hydrochlorothiazide was approved for medical use in the United States in October 1986.[2][3]
References
- ^ "Enalapril / hydrochlorothiazide (Vaseretic) Use During Pregnancy". Drugs.com. 29 May 2019. Retrieved 26 April 2020.
- ^ a b c d e f "Vaseretic- enalapril maleate and hydrochlorothiazide tablet". DailyMed. Retrieved 7 February 2022.
- ^ "Vaseretic: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on 1 May 2017. Retrieved 26 April 2020.
Further reading
- Frishman WH, Goldberger J, Sherman D (December 1987). "Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension". J Clin Hypertens. 3 (4): 520–7. PMID 2839628.